About the journal
CMI Communications is an open-access journal published by Elsevier in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,520 USD. Declared review time at DOAJ: 14 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 2950-5909
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,520 USD
- Articles in DOAJ
- 117
- Declared review time
- 14 weeks
- Declared peer-review model
- other
- Official website
- https://www.sciencedirect.com/journal/cmi-communications
Index listings
- DOAJ · 2025-03-03
- Indexing
- DOAJ
- APC
- 2,520 USD
- Declared review time (DOAJ)
- 14 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
117
Most recent article
last month
Average review time (journal-declared via DOAJ)
14weeks
Works in OpenAlex
179
Last recorded publication year
2026
h-index
7
i10-index
5
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2025-03-03
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 92%
- ORCID iDs in current deposits
- 64%
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9919257996106676
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- Antibiotic Use and Resistance
- Antibiotic Use and Resistance
- Antibiotic Use and Resistance
- Antibiotic Resistance in Bacteria
- Antibiotics Pharmacokinetics and Efficacy
- Antibiotic Resistance in Bacteria
- Pneumonia and Respiratory Infections
- Pneumonia and Respiratory Infections
Show all subjects (75)
- Antibiotic Resistance in Bacteria
- Urinary Tract Infections Management
- Urinary Tract Infections Management
- Fungal Infections and Studies
- Urinary Tract Infections Management
- Bacterial Identification and Susceptibility Testing
- Antibiotics Pharmacokinetics and Efficacy
- Antibiotics Pharmacokinetics and Efficacy
- Antimicrobial Resistance in Staphylococcus
- Bacterial Identification and Susceptibility Testing
- Infection Control in Healthcare
- Bacterial Identification and Susceptibility Testing
- Antimicrobial Resistance in Staphylococcus
- Infective Endocarditis Diagnosis and Management
- Academic Publishing and Open Access
- Antifungal resistance and susceptibility
- Infective Endocarditis Diagnosis and Management
- Sepsis Diagnosis and Treatment
- Orthopedic Infections and Treatments
- Antifungal resistance and susceptibility
- Zoonotic diseases and public health
- Antifungal resistance and susceptibility
- Zoonotic diseases and public health
- Infective Endocarditis Diagnosis and Management
- Streptococcal Infections and Treatments
- Pneumonia and Respiratory Infections
- Nosocomial Infections in ICU
- Reproductive tract infections research
- Reproductive tract infections research
- Antimicrobial Resistance in Staphylococcus
- Academic Publishing and Open Access
- Academic Publishing and Open Access
- Infectious Diseases and Tuberculosis
- Nosocomial Infections in ICU
- Infections and bacterial resistance
- Fungal Infections and Studies
- Orthopedic Infections and Treatments
- Orthopedic Infections and Treatments
- Tuberculosis Research and Epidemiology
- Pneumocystis jirovecii pneumonia detection and treatment
- Pneumocystis jirovecii pneumonia detection and treatment
- Virology and Viral Diseases
- Viral Infections and Outbreaks Research
- Viral Infections and Outbreaks Research
- Tuberculosis Research and Epidemiology
- Fungal Infections and Studies
- Gut microbiota and health
- Publishing and Scholarly Communication
- Pneumocystis jirovecii pneumonia detection and treatment
- SARS-CoV-2 and COVID-19 Research
- Reproductive tract infections research
- Vaccine Coverage and Hesitancy
- Bacterial Infections and Vaccines
- Clostridium difficile and Clostridium perfringens research
- Herpesvirus Infections and Treatments
- Pelvic floor disorders treatments
- Mosquito-borne diseases and control
- Herpesvirus Infections and Treatments
- Pelvic floor disorders treatments
- Mosquito-borne diseases and control
- Neutropenia and Cancer Infections
- Vaccine Coverage and Hesitancy
- Social Media in Health Education
- Clostridium difficile and Clostridium perfringens research
- Social Media in Health Education
- Meta-analysis and systematic reviews
- Meta-analysis and systematic reviews
Keywords (DOAJ)
- infectious diseases
- clinical microbiology
- infection control
- immunology
- epidemiology
- public health
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ